Patricia Koenig

Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma

Stephen M. Ansell, Sara A. Hurvitz, Patricia Koenig et al. · Clinical Cancer Research · 2009 · 332 citations · Full text

Medicine, Oncology, Pharmacology +17

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

Stephen M. Ansell, Hui Tang, Paul J. Kurtin et al. · The Lancet Oncology · 2011 · 154 citations · Full text

Medicine, Immunology, Oncology +12

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Han W. Tun, Patrick B. Johnston, Lisa M. DeAngelis et al. · Blood · 2018 · 133 citations · Full text

Medicine, Oncology, Pharmacotherapy +6

CP7_E2alf: A safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV)

Patricia Koenig, Elke Lange, Ilona Reimann et al. · Vaccine · 2007 · 68 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine

Patricia Koenig, Bernd Hoffmann, Klaus Depner et al. · Veterinary Microbiology · 2006 · 45 citations

Veterinary Medicine, Infectious Diseases, Veterinary Microbiology +17